Strategic Partnership Enhances Cancer Care through New Alliance of Chesapeake Oncology-Hematology Associates

Strengthening Cancer Care: The New Alliance between Chesapeake Oncology-Hematology Associates and Chesapeake Urology Associates

On January 5, 2026, Provident Healthcare Partners, a renowned healthcare investment banking firm, announced a significant strategic alliance between Chesapeake Oncology-Hematology Associates (COHA) and Chesapeake Urology Associates (CUA). This collaboration aims to elevate oncology services and patient care in the DMV region. For over 25 years, COHA has established itself as a leading provider of cancer care, with an emphasis on personalized treatments options such as immunotherapy, catering to patients across Anne Arundel, Howard, and Queen Anne's Counties.

The Partnership Dynamics

The announcement was made public during a remarkable press release emphasizing that the partnership would incorporate CUA, affiliated with the United Urology Group under the OneOncology umbrella. This merger is poised to reshape the landscape of cancer treatment by integrating urology with oncology, a progressive step aimed at streamlining patient experience and enhancing care delivery.

Dustin Thompson, Director at Provident, and Tommy Spiegel, Vice President, spearheaded the advisory team in this impactful deal. The strategic integration aims to offer a more cohesive approach to cancer care, facilitating comprehensive services that address patient needs holistically.

Insights from Leadership

Dr. Gayatri Nimmagadda, the President of COHA, expressed profound gratitude towards Provident for their exceptional advisory support. She stated, "Joining Chesapeake Urology Associates is key to our mission of delivering world-class cancer care, and we appreciate Provident’s guidance throughout this process."

Thompson highlighted the importance of this strategic alliance, mentioning how it redefines the collaboration between specialty groups to enhance clinical value and make high-quality care more accessible for patients from their local communities. This sentiment was echoed by Spiegel, who noted the crucial roles that oncology and urology play in cancer diagnosis and treatment.

The Broader Impact on Patient Care

The collaboration is expected to broaden access to healthcare services, improve care coordination, and ultimately bolster patient outcomes throughout the region. This integrated model of care will innovate patient services by expediting the processes of diagnosis, treatment, and managing care, making it more efficient and patient-centric.

The advancements made by COHA over the years, focusing on state-of-the-art biomarker-driven therapies, have already set high standards for cancer care in Maryland. With the addition of Chesapeake Urology, patients can expect a seamlessly integrated service that prioritizes convenience and comprehensive support.

About the Organizations Involved

Chesapeake Oncology-Hematology Associates (COHA)
Renowned for their compassionate care, COHA stands at the forefront of cancer treatment in Maryland. Their commitment to providing personalized care with advanced treatments such as immunotherapy positions them as a trusted partner for patients in need.

Chesapeake Urology Associates (CUA)
A respected entity in the urology field, CUA provides a patient-focused continuum of care tailored to enhance health outcomes. By collaborating with COHA, they aim to integrate their specialties further, strengthening the cancer care narrative in the region.

United Urology Group and OneOncology
Aiming to enhance urologic care, United Urology Group supports a cohesive care model that benefits both providers and patients. OneOncology serves as a platform to assist community practices, ensuring they can maintain independence while offering superior care at lower costs.

Conclusion

The partnership between COHA and CUA heralds a new era in cancer care, driven by the desire to deliver high-quality, accessible health services. With Provident Healthcare Partners’ strategic guidance, this merger is bound to create synergies that enhance patient outcomes and redefine care pathways for communities within the DMV area. As healthcare continues to evolve, this collaboration stands out as a model of how integrated services can have a transformative impact on patient care.

For more information, explore the individual websites of COHA, Chesapeake Urology Associates, and Provident Healthcare Partners.